Progenitor Cells in Airway Repair

气道修复中的祖细胞

基本信息

项目摘要

Project Summary/Abstract: Lung transplantation is often the only viable therapeutic option for end-stage pulmonary disorders. Unfortunately, lung transplantation is associated with numerous serious complications including acute rejection and bronchiolitis obliterans syndrome (BOS). Studies have indicated that immune-mediated injury and loss of airway epithelial cells is critical in the pathogenesis of BOS. Targeting this biology could therefore provide a major breakthrough for developing new therapeutic strategies for preventing rejection in lung transplantation. We have identified circulating epithelial progenitor cells (CEPC) that are recruited to the injured airway and aid in repair of the epithelium. These cells express cytokeratin 5, a marker of progenitor basal epithelial cells in the airway, and traffic via the CXCR4/CXCL12 biological axis. Consistent with the importance of CEPC in airway repair, blocking the recruitment of CEPC with neutralizing antibodies to CXCL12 resulted in the phenotype of squamous metaplasia. This implies that the interaction between circulating and resident progenitor epithelial cells in the airway niche is critical for normal airway repair. We hypothesize that enhancing engraftment of recipient CEPC into donor airway epithelium after lung transplantation will improve epithelial repair, result in less allo-recognition of the donor lung and ultimately reduce BOS. The goal of this proposal is to: 1) investigate the role of resident and circulating epithelial progenitor cell populations in the development of BOS by selectively eliminating these cell populations, 2) examine the effect of enhanced mobilization of CEPC on the development of BOS and 3) use patient lung transplant blood samples to determine whether CEPC correlate with patient outcome. The proposed studies will allow us to further understanding of the role of epithelial progenitor cells in the airway and will enable the harnessing of the therapeutic potential of CEPC.
项目总结/文摘:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRIGITTE N GOMPERTS其他文献

BRIGITTE N GOMPERTS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRIGITTE N GOMPERTS', 18)}}的其他基金

Developing a targeted chemoprevention strategy for Non-Small Cell Lung Cancer
制定非小细胞肺癌的靶向化学预防策略
  • 批准号:
    9170948
  • 财政年份:
    2016
  • 资助金额:
    $ 38.12万
  • 项目类别:
Progenitor Cells in Airway Repair
气道修复中的祖细胞
  • 批准号:
    8528692
  • 财政年份:
    2009
  • 资助金额:
    $ 38.12万
  • 项目类别:
Progenitor Cells in Airway Repair
气道修复中的祖细胞
  • 批准号:
    8123270
  • 财政年份:
    2009
  • 资助金额:
    $ 38.12万
  • 项目类别:
Progenitor Cells in Airway Repair
气道修复中的祖细胞
  • 批准号:
    7568010
  • 财政年份:
    2009
  • 资助金额:
    $ 38.12万
  • 项目类别:
Progenitor Cells in Airway Repair
气道修复中的祖细胞
  • 批准号:
    7766243
  • 财政年份:
    2009
  • 资助金额:
    $ 38.12万
  • 项目类别:
Cytokine Regulation of the Pulmonary Epithelium
肺上皮细胞因子的调节
  • 批准号:
    6860476
  • 财政年份:
    2004
  • 资助金额:
    $ 38.12万
  • 项目类别:
Cytokine Regulation of the Pulmonary Epithelium
肺上皮细胞因子的调节
  • 批准号:
    6994423
  • 财政年份:
    2004
  • 资助金额:
    $ 38.12万
  • 项目类别:
Cytokine Regulation of the Pulmonary Epithelium
肺上皮细胞因子的调节
  • 批准号:
    7534033
  • 财政年份:
    2004
  • 资助金额:
    $ 38.12万
  • 项目类别:
Cytokine Regulation of the Pulmonary Epithelium
肺上皮细胞因子的调节
  • 批准号:
    7154784
  • 财政年份:
    2004
  • 资助金额:
    $ 38.12万
  • 项目类别:
Cytokine Regulation of the Pulmonary Epithelium
肺上皮细胞因子的调节
  • 批准号:
    7326813
  • 财政年份:
    2004
  • 资助金额:
    $ 38.12万
  • 项目类别:

相似海外基金

Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
  • 批准号:
    26462277
  • 财政年份:
    2014
  • 资助金额:
    $ 38.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
  • 批准号:
    8344380
  • 财政年份:
    2012
  • 资助金额:
    $ 38.12万
  • 项目类别:
Allografting for Lukemia
白血病同种异体移植
  • 批准号:
    8260361
  • 财政年份:
    2011
  • 资助金额:
    $ 38.12万
  • 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
  • 批准号:
    7878675
  • 财政年份:
    2009
  • 资助金额:
    $ 38.12万
  • 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
  • 批准号:
    7677758
  • 财政年份:
    2009
  • 资助金额:
    $ 38.12万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    7466112
  • 财政年份:
    2008
  • 资助金额:
    $ 38.12万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    8010394
  • 财政年份:
    2008
  • 资助金额:
    $ 38.12万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    8208131
  • 财政年份:
    2008
  • 资助金额:
    $ 38.12万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    7575273
  • 财政年份:
    2008
  • 资助金额:
    $ 38.12万
  • 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
  • 批准号:
    7765518
  • 财政年份:
    2008
  • 资助金额:
    $ 38.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了